{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:29:36Z","timestamp":1757618976545,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,7]]},"DOI":"10.7759\/cureus.91770","type":"journal-article","created":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:02:09Z","timestamp":1757253729000},"source":"Crossref","is-referenced-by-count":0,"title":["Aggressive Follicular Lymphoma of the Breast: An Unusual Suspect"],"prefix":"10.7759","author":[{"given":"Kabeer","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Mikulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasnuva","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter JR","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1059914","article-title":"The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends","volume":"13","author":"Chu Y","year":"2023","unstructured":"Chu Y, Liu Y, Fang X, et al.. The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends. Front Oncol. 2023, 13:1059914. 10.3389\/fonc.2023.1059914","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22376-1","article-title":"Trends and projections of non-Hodgkin lymphoma burden (1990-2040): a global burden of disease 2021 analysis","volume":"25","author":"Wang S","year":"2025","unstructured":"Wang S, Zhou H, Liu Y, Li Y, Nie L. Trends and projections of non-Hodgkin lymphoma burden (1990-2040): a global burden of disease 2021 analysis. BMC Public Health. 2025, 25:1223. 10.1186\/s12889-025-22376-1","journal-title":"BMC Public Health"},{"key":"ref3","unstructured":"Cancer stat facts. non-Hodgkin lymphoma. (2024). Accessed: September 4, 2024: https:\/\/seer.cancer.gov\/statfacts\/html\/nhl.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2017.05.007","article-title":"Hematolymphoid lesions of the breast","volume":"34","author":"Hoffmann J","year":"2017","unstructured":"Hoffmann J, Ohgami RS. Hematolymphoid lesions of the breast. Semin Diagn Pathol. 2017, 34:462-9. 10.1053\/j.semdp.2017.05.007","journal-title":"Semin Diagn Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2011.0023","article-title":"Extranodal manifestations of lymphoma on [\u00b9\u2078F]FDG-PET\/CT: a pictorial essay","volume":"11","author":"Kashyap R","year":"2011","unstructured":"Kashyap R, Rai Mittal B, Manohar K, et al.. Extranodal manifestations of lymphoma on [\u00b9\u2078F]FDG-PET\/CT: a pictorial essay. Cancer Imaging. 2011, 11:166-74. 10.1102\/1470-7330.2011.0023","journal-title":"Cancer Imaging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26737","article-title":"Follicular lymphoma: 2023 update on diagnosis and management","volume":"97","author":"Jacobsen E","year":"2022","unstructured":"Jacobsen E. Follicular lymphoma: 2023 update on diagnosis and management. Am J Hematol. 2022, 97:1638-51. 10.1002\/ajh.26737","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2015.05.009","article-title":"The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment","volume":"39","author":"Sancho JM","year":"2015","unstructured":"Sancho JM, Garc\u00eda O, Mercadal S, et al.. The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment. Leuk Res. 2015, 39:853-8. 10.1016\/j.leukres.2015.05.009","journal-title":"Leuk Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2174804","article-title":"Follicular lymphoma: an update on biology and optimal therapy","volume":"64","author":"Fischer L","year":"2023","unstructured":"Fischer L, Dreyling M. Follicular lymphoma: an update on biology and optimal therapy. Leuk Lymphoma. 2023, 64:761-75. 10.1080\/10428194.2023.2174804","journal-title":"Leuk Lymphoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp238","article-title":"Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group","volume":"20","author":"Martinelli G","year":"2009","unstructured":"Martinelli G, Ryan G, Seymour JF, et al.. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2009, 20:1993-9. 10.1093\/annonc\/mdp238","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24937","article-title":"Follicular lymphoma: 2018 update on diagnosis and management","volume":"93","author":"Freedman A","year":"2018","unstructured":"Freedman A. Follicular lymphoma: 2018 update on diagnosis and management. Am J Hematol. 2018, 93:296-305. 10.1002\/ajh.24937","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000115","article-title":"Transformed lymphoma: what should I do now?","volume":"2020","author":"Smith S","year":"2020","unstructured":"Smith S. Transformed lymphoma: what should I do now?. Hematology Am Soc Hematol Educ Program. 2020, 2020:306-11. 10.1182\/hematology.2020000115","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2017.10.006","article-title":"Pathogenesis of follicular lymphoma","volume":"31","author":"Lackraj T","year":"2018","unstructured":"Lackraj T, Goswami R, Kridel R. Pathogenesis of follicular lymphoma. Best Pract Res Clin Haematol. 2018, 31:2-14. 10.1016\/j.beha.2017.10.006","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25696","article-title":"Follicular lymphoma: 2020 update on diagnosis and management","volume":"95","author":"Freedman A","year":"2020","unstructured":"Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol. 2020, 95:316-27. 10.1002\/ajh.25696","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2019180097","article-title":"Primary and secondary breast lymphoma: clinical, pathologic, and multimodality imaging review","volume":"39","author":"Raj SD","year":"2019","unstructured":"Raj SD, Shurafa M, Shah Z, Raj KM, Fishman MD, Dialani VM. Primary and secondary breast lymphoma: clinical, pathologic, and multimodality imaging review. Radiographics. 2019, 39:610-25. 10.1148\/rg.2019180097","journal-title":"Radiographics"},{"key":"ref15","article-title":"Follicular Lymphoma","author":"Kaseb H","year":"2025","unstructured":"Kaseb H, Ali MA, Gasalberti DP, Koshy NV. Follicular Lymphoma. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34221","article-title":"Mortality among patients with low-grade follicular lymphoma: a binational retrospective analysis","volume":"128","author":"Rajam\u00e4ki A","year":"2022","unstructured":"Rajam\u00e4ki A, Hujo M, Sund R, et al.. Mortality among patients with low-grade follicular lymphoma: a binational retrospective analysis. Cancer. 2022, 128:2474-82. 10.1002\/cncr.34221","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw294","article-title":"Primary breast lymphoma in the United States: 1975-2013","volume":"109","author":"Thomas A","year":"2017","unstructured":"Thomas A, Link BK, Altekruse S, Romitti PA, Schroeder MC. Primary breast lymphoma in the United States: 1975-2013. J Natl Cancer Inst. 2017, 109:294. 10.1093\/jnci\/djw294","journal-title":"J Natl Cancer Inst"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.85831","article-title":"Primary breast lymphoma: a rare presentation of diffuse large B-cell lymphoma, germinal center B-cell subtype (DLBCL-GCB)","volume":"17","author":"Chrysikos D","year":"2025","unstructured":"Chrysikos D, Livieratou E, Giannouli S, et al.. Primary breast lymphoma: a rare presentation of diffuse large B-cell lymphoma, germinal center B-cell subtype (DLBCL-GCB). Cureus. 2025, 17:e85831. 10.7759\/cureus.85831","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-68. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284538","article-title":"Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study","volume":"109","author":"Barraclough A","year":"2024","unstructured":"Barraclough A, Agrawal S, Talaulikar D, et al.. Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study. Haematologica. 2024, 109:3338-45. 10.3324\/haematol.2023.284538","journal-title":"Haematologica"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01635.x","article-title":"Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma","volume":"101","author":"Ohmachi K","year":"2010","unstructured":"Ohmachi K, Ando K, Ogura M, et al.. Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Cancer Sci. 2010, 101:2059-64. 10.1111\/j.1349-7006.2010.01635.x","journal-title":"Cancer Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01073","article-title":"Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: Long-term results of the PRIMA study","volume":"37","author":"Bachy E","year":"2019","unstructured":"Bachy E, Seymour JF, Feugier P, et al.. Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: Long-term results of the PRIMA study. J Clin Oncol. 2019, 37:2815-24. 10.1200\/JCO.19.01073","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1085528","article-title":"Systematic review of the recent evidence for the efficacy and safety of chlorambucil in the treatment of B-cell malignancies","volume":"57","author":"Lepretre S","year":"2016","unstructured":"Lepretre S, Dartigeas C, Feugier P, Marty M, Salles G. Systematic review of the recent evidence for the efficacy and safety of chlorambucil in the treatment of B-cell malignancies. Leuk Lymphoma. 2016, 57:852-65. 10.3109\/10428194.2015.1085528","journal-title":"Leuk Lymphoma"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/377000-aggressive-follicular-lymphoma-of-the-breast-an-unusual-suspect","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:02:10Z","timestamp":1757253730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/377000-aggressive-follicular-lymphoma-of-the-breast-an-unusual-suspect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,7]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.91770","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,7]]}}}